White Paper
Accelerating Time to IND with Pharma 4.0
![Accelerating Time to IND with Pharma 4.0](/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_product_file/publications/pharmaceutical-science/biopharma-reporter.com/library/accelerating-time-to-ind-with-pharma-4.0/15786342-1-eng-GB/Accelerating-Time-to-IND-with-Pharma-4.0.jpg)
The future of the biopharmaceutical industry hinges on its adoption of 21st-century digital tools and automation. In this article, leadership from disruptive new biopharmaceutical CDMO Wheeler Bio discuss the benefits of forward-looking digitalization and collaboration in the industry. Following Pharma 4.0 principles, Wheeler Bio is working to integrate hardware, software, and biology to deliver a new tier of biomanufacturing quality, clinical timelines, and data transparency for emerging biotech companies.